← Back to headlines
Johnson & Johnson's $1 Billion Oncology Bet
Johnson & Johnson has triggered a $1 billion bet in the oncology sector, prompting analysis on whether its stock is a buy at $238.
11 Jun, 16:07 — 11 Jun, 16:07
Sources
Showing 1 of 1 sources
